Kozono, David

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature

Cancer Immunotherapy and BiomarkersRNA regulation and disease

Cited by 697

A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy

Kang, J., D’Andrea, A. D., & Kozono, D. (2012) · JNCI: Journal of the National Cancer Institute

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 167

Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas

Pal, S., Kozono, D., Yang, X., Fendler, W., Fitts, W., Ni, J., Alberta, J. A., Zhao, J., Liu, K. X., Bian, J., et al. (2018) · Cancer Research

Glioma Diagnosis and TreatmentChromatin Remodeling and Cancer

Cited by 101

Conversion of aquaporin 6 from an anion channel to a water-selective channel by a single amino acid substitution

Liu, K., Kozono, D., Kato, Y., Agre, P., Hazama, A., & Yasui, M. (2005) · Proceedings of the National Academy of Sciences

Ion Transport and Channel RegulationIon channel regulation and function

Cited by 84

Natural Language Processing Methods to Empirically Explore Social Contexts and Needs in Cancer Patient Notes

Derton, A., Guevara, M., Chen, S., Moningi, S., Kozono, D. E., Liu, D., Miller, T. A., Savova, G. K., Mak, R. H., & Bitterman, D. S. (2023) · JCO Clinical Cancer Informatics

Machine Learning in HealthcareComputational and Text Analysis Methods

Cited by 8